February 28, 2018 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Genmab A/S, a stock transaction, valued at $1,001 - $15,000. The trade took place on February 28, 2018 and was disclosed on March 6, 2018 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.